Neogen Corporation operates in food safety diagnostics with significant international revenue exposure, but declining top-line growth, weak quality scores, and a high concentration in a single product segment create structural headwinds that outweigh its favorable momentum setup.
Thesis pillars
- Revenue Decline Quality Floor→Stable
- Food Safety Segment Concentration↑Improving
- Earnings Consistency Mixed→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Jul 30, 2026
Neogen Corporation (NEOG) Stock Analysis
Range Bound setup
Healthcare · Medical Devices
Sell if holding. Engine safety override at $12.12: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 3.67; Below-average business quality.
Neogen develops and sells food safety diagnostics (pathogen, allergen and toxin test kits, culture media, Petrifilm plates) and animal safety products (veterinary instruments, pharmaceuticals, rodent control, genomics services) through its own sales staff and distributors in... Read more
Sell if holding. Engine safety override at $12.12: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 3.67; Below-average business quality. Chart setup: RSI 57 mid-range, Bollinger mid-band. Score 5.8/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 70d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
About Neogen Corporation
About Neogen Corporation
Neogen's Food Safety segment -- diagnostic test kits and culture media sold to food and feed producers -- generated 71.3% of total revenue in fiscal 2025, up from 66.5% two years earlier following the 2022 Reverse Morris Trust combination with 3M's Food Safety Division, while the Animal Safety segment contributed the remaining 28.7%. Sales to customers outside the United States accounted for 50.2% of fiscal 2025 revenue, and the company manufactures products across facilities in the U.S., U.K., Ireland and Brazil.
Neogen earns Food Safety revenue mainly from single-use diagnostic test kits and culture media that detect pathogens, allergens, toxins and sanitation issues, sold to food and feed processors and regulatory agencies, with royalty payments of 2% to 10% of revenue owed on products using licensed detection technology. The Animal Safety segment sells veterinary instruments, pharmaceuticals, vaccines, parasiticides, rodent and insect control products, and genomics testing services through veterinarians, retailers, livestock producers and distributors, and in April 2025 the company agreed to sell its global Cleaners and Disinfectants business. Neogen distributes through its own sales force in 28 countries outside the U.S. plus a network of distributors reaching more than 100 countries, and it operates genomics labs in six countries. Certain Food Safety product lines depend on a sole or single-source supplier or vendor for raw materials, a dependency the company flags directly in its risk factors.
Show full overview
Neogen's sole-source supplier risk is compounded by proprietary sourcing: the 10-K discloses that it currently purchases some raw materials and products from sole or single sources, and that some of these inputs are proprietary and therefore cannot be readily or easily replaced by alternative sources. That combination -- single-source plus non-substitutable -- sits alongside a separate risk that the company's Food Safety reporting unit took goodwill impairment charges in the second and fourth quarters of fiscal 2025 tied to difficulties integrating the 3M Food Safety business, a transaction that made pre-merger Neogen Food Safety Corporation stockholders owners of roughly 50.1% of combined shares in September 2022.
See also: Healthcare · Medical Devices
From Neogen Corporation's most recent 10-K filing, extracted October 18, 2026.
Recent developments
updated 2026-10-29Recent Developments — Neogen Corporation
Latest news
- NEWS Why Is Neogen Stock Gaining Thursday? — benzinga Oct 8, 2026 positive
- NEWS Reported Earlier, Neogen Outlines Growth And Margin Expansion Strategy At 2026 Investor Day, Targeting High-Single-Digit — benzinga Oct 8, 2026 positive
- NEWS Neogen Shifts Focus to Scale Profitable Growth — benzinga Oct 7, 2026 positive
- NEWS 12 Health Care Stocks Moving In Wednesday's Pre-Market Session — benzinga Oct 7, 2026 neutral
- NEWS Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket — benzinga Oct 7, 2026 neutral
Generated 2026-10-29T11:14:34Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSupplier3M plants manufacturing Petrifilm10-K Item 1: 'Petrifilm product line are currently manufactured within 3M plants in the U.S. and Poland'
- HIGHSuppliersole or single source raw materials and products10-K Item 1A: 'we currently purchase some raw materials and products from sole or single sources'
Material Events(8-K, last 90d)
- 2026-08-07Item 5.02LOWDirector Thierry Bernard resigned from the Board of Directors on August 3, 2026. No reason cited and no replacement named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Unprofitable operations — net margin -6.3%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $12.12: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Elevated put/call ratio: 3.67; Below-average business quality. Chart setup: RSI 57 mid-range, Bollinger mid-band. Prior stop was $11.27. Score 5.8/10, moderate confidence.
Analyst target $11.90 reached (−1.8% from $12.12); no take-profit level is published. Prior stop was $11.27. Stop-loss: $11.27.
Concentration risk — Supplier: sole or single source raw materials and products; Target reached (-1.8% upside); Quality below floor (3.6 < 4.0).
Neogen Corporation trades at a P/E of N/A (forward 26.9). TrendMatrix value score: 5.4/10. Verdict: Sell.
11 analysts cover NEOG with a consensus score of 4.0/5. Average price target: $14.
What does Neogen Corporation do?Neogen develops and sells food safety diagnostics (pathogen, allergen and toxin test kits, culture media, Petrifilm...
Neogen develops and sells food safety diagnostics (pathogen, allergen and toxin test kits, culture media, Petrifilm plates) and animal safety products (veterinary instruments, pharmaceuticals, rodent control, genomics services) through its own sales staff and distributors in more than 100 countries. Customers outside the U.S. were 51.2% of fiscal 2026 revenue. Most test kits are single-use consumables, and the genomics unit is being sold to Zoetis for $160.0 million.